ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,967.84
-0.22%
US Tech 100
21,102.40
-0.27%
Dow Jones
42,206.82
0.08%
Brent Oil
76.125
0.00%
Bitcoin
103,504.22
0.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ChromaDex Corporation (CDXC) Quote

ChromaDex Corporation

ChromaDex Corporation (CDXC)

NASDAQ
7.87
0.00
(0.00%)
Closed June 21 4:00PM
15 min delayed - Upgrade to Realtime
0.00
0.00
(0.00%)
After Hours: -
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
7.87
Bid
7.75
Ask
8.00
Volume
-
0.00 Day's Range 0.00
2.305 52 Week Range 9.18
Market Cap
611.896M
Previous Close
7.87
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
77,750,447
Dividend Yield
-
PE Ratio
71.55
Earnings Per Share (EPS)
0.11
Revenue
99.6M
Net Profit
8.55M

About ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. Show more

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
www.niagenbioscience.com
Headquarters
Dover, Delaware, USA
Founded
-
ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker CDXC. The last closing price for ChromaDex was $7.87. Over the last year, ChromaDex shares have traded in a share price range of $ 2.305 to $ 9.18.

ChromaDex currently has 77,750,447 shares outstanding. The market capitalization of ChromaDex is $611.90 million. ChromaDex has a price to earnings ratio (PE ratio) of 71.55.

Ask ADVFN Intelligence (AI)

CDXC Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
March 19 2025
CDXC (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 10 2025
CDXC (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
March 04 2025
CDXC (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
March 04 2025
CDXC (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 27 2025
CDXC (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
February 27 2025
CDXC (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 14 2025
CDXC (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 14 2025
CDXC (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 14 2025
CDXC (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1007.877.877.8700CS
4007.877.877.8700CS
12007.877.877.8700CS
262.5648.21092278725.319.185.163835227.20935987CS
525.07181.0714285712.89.182.3055844256.0406435CS
1566.16360.2339181291.719.181.153319194.40330433CS
2603.2369.61206896554.6423.661.155412758.38895155CS

CDXC - Frequently Asked Questions (FAQ)

What is the current ChromaDex share price?
The current share price of ChromaDex is $ 7.87
How many ChromaDex shares are in issue?
ChromaDex has 77,750,447 shares in issue
What is the market cap of ChromaDex?
The market capitalisation of ChromaDex is USD 611.9M
What is the 1 year trading range for ChromaDex share price?
ChromaDex has traded in the range of $ 2.305 to $ 9.18 during the past year
What is the PE ratio of ChromaDex?
The price to earnings ratio of ChromaDex is 71.55
What is the cash to sales ratio of ChromaDex?
The cash to sales ratio of ChromaDex is 6.14
What is the reporting currency for ChromaDex?
ChromaDex reports financial results in USD
What is the latest annual turnover for ChromaDex?
The latest annual turnover of ChromaDex is USD 99.6M
What is the latest annual profit for ChromaDex?
The latest annual profit of ChromaDex is USD 8.55M
What is the registered address of ChromaDex?
The registered address for ChromaDex is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904
What is the ChromaDex website address?
The website address for ChromaDex is www.niagenbioscience.com
Which industry sector does ChromaDex operate in?
ChromaDex operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXTTNext Technology Holding Inc
$ 3.44
(158.65%)
13.84M
WHLRWheeler Real Estate Investment Trust Inc
$ 7.15
(109.06%)
52.35M
CTORCitius Oncology Inc
$ 2.63
(69.68%)
20.77M
LUCYInnovative Eyewear Inc
$ 3.52
(54.39%)
111.21M
LGCLLucas GC Ltd
$ 1.0407
(53.16%)
11.17M
NWGLNature Wood Group Ltd
$ 1.71
(-69.63%)
3.99M
ICUSeaStar Medical Holding Corporation
$ 0.351
(-64.05%)
21.9M
MBRXMoleculin Biotech Inc
$ 0.259999
(-55.40%)
16.84M
RGCRegencell Bioscience Holdings Ltd
$ 37.50
(-40.81%)
2.22M
CGTLCreative Global Technology Holdings Ltd
$ 1.4399
(-36.57%)
6.71M
HCTIHealthcare Triangle Inc
$ 0.0297
(12.08%)
583.72M
DFLIDragonfly Energy Holdings Corporation
$ 0.245
(12.39%)
334.37M
GNLNGreenlane Holdings Inc
$ 0.009
(-13.04%)
262.88M
NVDANVIDIA Corporation
$ 143.85
(-1.12%)
242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.359
(-0.09%)
193.97M

CDXC Discussion

View Posts
TrendTrade2016 TrendTrade2016 7 months ago
CDXC 7 DOLLA BREAK...BEAST
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
cdxc heres 7 bucks
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CDXC HERE COMES 7 BUCKS
👍️0
tredenwater2 tredenwater2 7 months ago
Amazing how you and your buddies show up here in a similar fashion and are just abead of robust MC increases after years of decline. You must be friends with or connected to HF managers that “get a little loose” after a few drinks.

The stories my brother shared, and others, about this are true.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CDXC MONSTER BREAK OUT
👍️0
gail gail 7 months ago
congrats!
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CDXS HEREW W E GO
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CDXS NEW 52 WEEK HIGH
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
HERE WE GO...BREAKING NEW 52 WEEK HIGH
👍️0
PonkenPlonken PonkenPlonken 7 months ago
The GRAS status allows it to be incorporated into conventional foods and beverages.
Most people arent biohacking fanatics.
Ty for mentioning NMN -- ill take a second look.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
THE NAD SPACE DOES NOT NEED FDA...BUT THIS IS THE ONLY PUBLIC NAD PLAY....NNM NOW BEING ALL THE RAGE!!
👍️0
PonkenPlonken PonkenPlonken 7 months ago
The competition is behind as CDXC has FDA safety review = "Generally recognized as safe" (GRAS) status + they have the patents.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
COMPANY HAS COMPETION NOW IN THE NAD SPACE...SO JUST A TRADE
👍️0
PonkenPlonken PonkenPlonken 7 months ago
You are right. If they change the apathic share-selling management that practically - for whatever reason - kept the trial results hidden from the public, this can go far.
Imagine the health and longevity influencers catching on. No media on this for now.
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CDXC LETS ROLL...COMPANY HAS THE NAD KING!!
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
CDXC HOLDING STRONG
👍️0
gail gail 8 months ago
it tried to anyway. lol
👍️0
gail gail 8 months ago
nice grab, its moving up now.
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
GRABBED THIS DIP....LOVE THIS COMPANY!!!
👍️0
Monksdream Monksdream 8 months ago
CDXC, new 52=week high
👍️0
Monroe1 Monroe1 8 months ago
Back in the green. Good company with a great product and huge demand building.
👍️0
Monksdream Monksdream 10 months ago
CDXC under $4
👍️0
Tiger Money Tiger Money 10 months ago
I have only added to my position here and plan on selling some at $25
👍️0
Sirpeter Sirpeter 10 months ago
Good call huh?
👍️0
Tiger Money Tiger Money 10 months ago
Agreed
👍️0
Sirpeter Sirpeter 10 months ago
Keep it now...I'm sticking with options in ABT, WDC and UBER...have some HUMA shares too...this will work also...Its in the Russell 2000 will be good with rate cuts...like both
👍️0
Tiger Money Tiger Money 10 months ago
Haven’t sold yet. U were confident and I’m confident in you!
👍️0
Sirpeter Sirpeter 10 months ago
Lol
👍️0
Tiger Money Tiger Money 10 months ago
I bought a bunch of huma yday. It will be a $25-50 stock as soon as the fda pulls its heads out of its asses
👍️0
Sirpeter Sirpeter 10 months ago
Dumped it...like Huma better
👍️0
Sirpeter Sirpeter 10 months ago
Still confident this will run soon...don't sell
👍️0
Tiger Money Tiger Money 10 months ago
I like the plan, thanks
👍️0
Sirpeter Sirpeter 10 months ago
Not enough improvement in the 2nd qtr to move the needle here yet...will hold it for a week and see what happens
👍️0
Sirpeter Sirpeter 10 months ago
Fingers crossed
👍️0
Tiger Money Tiger Money 10 months ago
I don’t plan on selling any ahead of time. I think I have about $4k in this one
👍️0
Sirpeter Sirpeter 10 months ago
This is a high risk reward play for now...will know tomorrow if got it right
👍️0
Tiger Money Tiger Money 10 months ago
Thanks! Trying to h to get caught up in this bloodbath
👍️0
Sirpeter Sirpeter 11 months ago

Gm Tiger
Earnings call here Weds...may not be good this qtr because of the major product roll-out...that's expensive... will still hold this one. not holding much else during this sell off...tech and bio will be good when it's over
👍️0
Tiger Money Tiger Money 11 months ago
Thanks. Crazy times in the markets!
👍️0
Sirpeter Sirpeter 11 months ago
Im still holding calls on all these...its a bit early for this one but it will come based on the valuation...most likely in the next qtr...hang in there...in the meantime I've been cleaning up over at ABT...also still waiting on PFE to go...all on positive guidence and Q reports...mkt down today on weak job numbers...its summer what do they expect?
👍️0
Tiger Money Tiger Money 11 months ago
Why has this been shorting the bed the last two weeks minus today’s market bloodbath? Add more or is it going to keep dropping? Thanks
👍️0
Tiger Money Tiger Money 11 months ago
Awesome, thanks!
👍️0
Sirpeter Sirpeter 11 months ago
Eventually about $10...so far I own 30 Nov calls...may add to them
👍️0
Tiger Money Tiger Money 11 months ago
Thanks! Price target?
👍️0
Sirpeter Sirpeter 11 months ago
Mass distribution of Niagen a suppliment that helps to extend life...lots of news under the news heading
👍️0
Tiger Money Tiger Money 11 months ago
Why do you feel so strong about this one? Thanks
👍️0
Tiger Money Tiger Money 11 months ago
I need to buy a couple thousand shares if I can remember tmrw! Work has been so busy!
👍️0
Sirpeter Sirpeter 11 months ago
Starting...
👍️0
Sirpeter Sirpeter 11 months ago
This one is starting...I alerted you
👍️0
Monksdream Monksdream 11 months ago
CDXC under $3
👍️0

Your Recent History

NASDAQ
CDXC
ChromaDex
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads